PF-Atlas › Clinical Trials › NCT05699148

Gut Imaging for Function and Transit in Cystic Fibrosis 3 Junior

Elexacaftor / Ivacaftor / Tezacaftor · Not specified

Registry ID
NCT05699148
Phase
Not specified
Status
Unknown
Drug / intervention
Elexacaftor / Ivacaftor / Tezacaftor
Sponsor
Nottingham University Hospitals NHS Trust
Start
2022-04-01

About this trial

Elexacaftor / Ivacaftor / Tezacaftor is evaluated in NCT05699148, a idiopathic pulmonary fibrosis study sponsored by Nottingham University Hospitals NHS Trust. Current status: Unknown.

View NCT05699148 on ClinicalTrials.gov →

Explore related

All Elexacaftor / Ivacaftor / Tezacaftor trialsAll IPF trials

Related trials

Elexacaftor / Ivacaftor / Tezacaftor — NCT05576324Elexacaftor / Ivacaftor / Tezacaftor — NCT07148739
Medical disclaimer. This page summarizes public trial data for NCT05699148 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.